𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Relevance of RIBA-3 supplementary test to HCV PCR positivity and genotypes for HCV confirmation of blood donors

✍ Scribed by Dow, B.C.; Buchanan, I.; Munro, H.; Follett, E.A.C.; Davidson, F.; Prescott, L.E.; Yap, P.L.; Simmonds, P.


Book ID
101215775
Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
485 KB
Volume
49
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


HCV antibody screening of 624,910 blood donations resulted in 3,832 samples being referred for confirmation. All were tested by RIBA-3 with 2,710 negative, 945 indeterminate and 177 positive results. HCV RNA was detected by PCR in an average of 69.5% of RIBA-3 positives (4 bands 84.1%; 3 bands 74.1%; 2 bands 34.1%) and only 0.53% of RIBA-3 indeterminates. Eighty-four percent of samples with a total RIBA-3 band intensity score (maximum 16) of 2 8 were PCR positive compared with only 22% of those with a score of <8. Total mean band intensities for HCV genotype 1 samples (n : 65) were 13.2, genotype 2 (n = 17) 11.4 and genotype 3 (n = 65) 11.2 with type 1 samples showing greater reactivity with clOO and c33 antibodies. No PCR positive type 1 samples were found with RIBA-3 total band scores less than 8, no PCR positive type 2 samples less than 6, whilst PCR positive type 3 samples were found with scores as low as 2. NS5 indeterminates were the most common (40.2%) single band pattern but yielded no PCR positive samples, followed by c33 (23.3%) with one PCR positive and clOO (20.2%) with one PCR positive whilst c22 indeterminates were least common (16.3%) but included three PCR positive donors. All five RIBA-3 indeterminate PCR positive donors were type 3. o 1996 Wiley-Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Reliability of hepatitis C virus core an
✍ Salah Agha; Yasuhito Tanaka; Niveen Saudy; Fuat Kurbanov; Mostafa Abo-Zeid; Moha πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 265 KB

## Abstract Nucleic acid amplification‐based methods are used for confirmation of viremia in antibody to hepatitis C virus (anti‐HCV)‐positive patients. However, this technology is labor intensive, time consuming, requires complex laboratory conditions, and expensive. The aim of this study was to e